The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting
单位：[1]Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India[2]Department of Medicine, Yong Loo Lin School ofMedicine, National University of Singapore, Singapore[3]Department of Gastroenterology and Hepatology, Princess Alexandra Hospital Brisbane, University of Queensland, Brisbane, Queensland, Australia[4]Department of Gastroenterology, China-Japan Friendship Hospital, Beijing[5]Fourth Military Medical University, Xi’an, China[6]Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea[7]Faculty of Medicine, University of Indonesia[8]RSUPN Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia[9]Department of Medicine, Division of Gastroenterology, Jichi Medical University, Shimotsuke, Tochigi, Japan[10]Division of Gastroenterology and Hepatology, Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, Texas, USA[11]Clinica de Gastroenterologia, Facultad de Medicina, Montevideo, Uruguay
The Asia-Pacific region is diverse, with regard to ethnicity, culture, and economic development incorporating some of the world's least and most developed nations. Gastrointestinal diseases are common in the Asia-Pacific region, and their prevalence, presentation, and management vary considerably within the region. There is growing evidence for an important role for the human gut microbiota in gastrointestinal health. As a consequence, geographic variations in the composition of the gut microbiota may contribute to variations in both the prevalence and response to therapy of specific diseases. Probiotics have been proposed as a valuable option in the prevention and treatment of a number of gastrointestinal illnesses, but the quality of available evidence to support their efficacy is variable. A meeting of international experts in adult and pediatric gastroenterology was held at the Sorbonne University, Paris, France, on April 11 and 12, 2016, to discuss current evidence supporting the use of probiotics in gastrointestinal disorders in the Asia-Pacific region. This article provides an overview of the discussions held at this meeting and recommends the formation of an Asia-Pacific Consortium on Gut Microbiota similar to those established in Europe and North America.
第一作者单位：[1]Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
通讯作者：
通讯机构：[10]Division of Gastroenterology and Hepatology, Lynda K and David M Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, Texas, USA[*1]Division of Gastroenterology and Hepatology, Houston Methodist Hospital, 6550 Fannin Street SM1201, Houston, TX 77030, USA.
推荐引用方式(GB/T 7714)：
Ghoshal Uday C.,Gwee Kok-Ann,Holtmann Gerald,et al.The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting[J].JOURNAL of GASTROENTEROLOGY and HEPATOLOGY.2018,33(1):57-69.doi:10.1111/jgh.13840.
APA：
Ghoshal, Uday C.,Gwee, Kok-Ann,Holtmann, Gerald,Li, Yanmei,Park, Soo Jung...&Cohen, Henry.(2018).The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting.JOURNAL of GASTROENTEROLOGY and HEPATOLOGY,33,(1)
MLA：
Ghoshal, Uday C.,et al."The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting".JOURNAL of GASTROENTEROLOGY and HEPATOLOGY 33..1(2018):57-69
